- Home
- EQBK vs TECX Comparison
EQBK vs TECX Comparison
Compare EQBK & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQBK
- TECX
- Stock Information
- Founded
- EQBK 2002
- TECX 2019
- Country
- EQBK United States
- TECX United States
- Employees
- EQBK N/A
- TECX N/A
- Industry
- EQBK Major Banks
- TECX
- Sector
- EQBK Finance
- TECX
- Exchange
- EQBK Nasdaq
- TECX Nasdaq
- Market Cap
- EQBK 750.4M
- TECX 647.7M
- IPO Year
- EQBK 2015
- TECX 2018
- Fundamental
- Price
- EQBK $43.98
- TECX $46.70
- Analyst Decision
- EQBK Hold
- TECX Strong Buy
- Analyst Count
- EQBK 4
- TECX 5
- Target Price
- EQBK $44.50
- TECX $72.25
- AVG Volume (30 Days)
- EQBK 56.3K
- TECX 87.8K
- Earning Date
- EQBK 01-22-2025
- TECX 11-07-2024
- Dividend Yield
- EQBK 1.32%
- TECX N/A
- EPS Growth
- EQBK N/A
- TECX N/A
- EPS
- EQBK 1.12
- TECX N/A
- Revenue
- EQBK $157,755,000.00
- TECX N/A
- Revenue This Year
- EQBK N/A
- TECX N/A
- Revenue Next Year
- EQBK $6.05
- TECX N/A
- P/E Ratio
- EQBK $40.52
- TECX N/A
- Revenue Growth
- EQBK N/A
- TECX N/A
- 52 Week Low
- EQBK $30.44
- TECX $1.40
- 52 Week High
- EQBK $50.85
- TECX $53.34
- Technical
- Relative Strength Index (RSI)
- EQBK 44.76
- TECX 57.31
- Support Level
- EQBK $45.10
- TECX $42.81
- Resistance Level
- EQBK $48.39
- TECX $51.37
- Average True Range (ATR)
- EQBK 1.25
- TECX 3.12
- MACD
- EQBK -0.44
- TECX -0.72
- Stochastic Oscillator
- EQBK 25.30
- TECX 55.94
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. The company's operation involves the delivery of loan and deposit products to customers. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.